Brigit Riley - Sep 19, 2022 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
Chief Scientific Officer
Signature
Brigit Riley, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
ADVM
Transactions as of
Sep 19, 2022
Transactions value $
-$7,772
Form type
4
Date filed
9/21/2022, 07:58 PM
Previous filing
Sep 16, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Sale -$7.77K -7.27K -5.77% $1.07 119K Sep 19, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
F2 Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.069589 to $1.075. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 Includes 6,000 shares purchased on May 20, 2022 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.